Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 3/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.36 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.33 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.33 |
| ▸ | NOS2 | P35228 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | SRC | P12931 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL43325 | 0.87 | SRC (0.42) | MIFCYP2D6LMNAALDH1A1SRC | |
| SCHEMBL1529163 | 0.86 | MIF (0.42) | MIFTAAR1AOC3CYP2D6ADRA2A | |
| SCHEMBL22589093 | 0.79 | TSHR (0.41) | MIFCYP2D6LMNAALDH1A1SRC | |
| SCHEMBL211770 | 0.78 | MIF (0.63) | MIFTAAR1CYP2D6ADRA2AADRA2C | |
| SCHEMBL7980 | 0.78 | MIF (0.63) | MIFTAAR1CYP2D6ADRA2AADRA2C | |
| SCHEMBL6583 | 0.78 | MIF (0.63) | MIFTAAR1CYP2D6ADRA2AADRA2C | |
| SCHEMBL23070416 | 0.78 | MIF (0.57) | MIFTAAR1CYP2D6ADRA2AADRA2C | |
| SCHEMBL27641530 | 0.78 | MIF (0.42) | MIFTAAR1AOC3CYP2D6ADRA2A | |
| SCHEMBL21300834 | 0.76 | TAAR1 (0.40) | MIFTAAR1AOC3CYP2D6ADRA2A | |
| SCHEMBL6298769 | 0.75 | MIF (0.44) | MIFTAAR1CYP2D6ADRA2AADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10418607-B2 | Slurry for secondary battery porous membranes, secondary battery porous membrane, secondary battery electrode, secondary battery separator, secondary battery, and method for producing secondary battery porous membrane | ZEON CORPORATION (JP) | 2019-09-17 | — | — | US | disclosed |
| US-20170107325-A1 | HYDROPHILIC POLYMER DERIVATIVE HAVING CYCLIC BENZYLIDENE ACETAL LINKER | NOF CORPORATION (JP) | 2017-04-20 | — | — | US | disclosed |
| EP-2755256-B1 | SLURRY FOR SECONDARY BATTERIES | ZEON CORP (JP) | 2016-10-26 | — | — | EP | disclosed |
| CN-103238234-B | Secondary cell perforated membrane slurry, secondary cell perforated membrane, electrode for secondary battery, secondary battery separator and secondary cell | 日本瑞翁株式会社 | 2016-08-10 | — | — | CN | disclosed |
| CN-103250273-B | Secondary cell perforated membrane slurry, secondary cell perforated membrane, electrode for secondary battery, secondary battery separator and secondary cell | ZEON CORP. (JP) | 2016-03-02 | — | — | CN | disclosed |
| EP-2626930-A1 | SLURRY FOR SECONDARY BATTERY POROUS MEMBRANE, SECONDARY BATTERY POROUS MEMBRANE, SECONDARY BATTERY ELECTRODE, SECONDARY BATTERY SEPARATOR, AND SECONDARY BATTERY | Zeon Corporation (JP) | 2013-08-14 | — | — | EP | disclosed |
| CN-103250273-A | Slurry for secondary battery porous membrane, secondary battery porous membrane, secondary battery electrode, secondary battery separator, and secondary battery | ZEON CORP | 2013-08-14 | — | — | CN | disclosed |
| CN-103238234-A | Secondary-battery porous-embrane slurry, secondary-battery porous membrane, secondary-battery electrode, secondary-battery separator, and secondary battery | ZEON CORP | 2013-08-07 | — | — | CN | disclosed |
| US-7589159-B2 | Process for producing radical polymer | TECHNO NETWORK SHIKOKU CO., LTD. (JP) | 2009-09-15 | — | — | US | disclosed |
| US-20070032615-A1 | Process for producing radical polymer | TECHNO NETWORK SHIKOKU CO., LTD. (JP) | 2007-02-08 | — | — | US | disclosed |
| CN-1280353-C | Heat convertible composition containing poly (arylidene ether), its producing process and products thereby | GEN ELECTRIC (US) | 2006-10-18 | — | — | CN | disclosed |
| CN-1816317-A | Composition comprising at least one substituted 2-[2-(4-amino phenyl)ethenyl]-1-pyridinium derivative, process for treating keratin fibres using it, device and use thereof | OREAL (FR) | 2006-08-09 | — | — | CN | disclosed |
| US-6812276-B2 | CURABLE MIXTURE OF A FUNCTIONALIZED POLY(ARYLENE ETHER) SUCH AS METHACRYLATE-ENDCAPPED POLY(2,6-DIMETHYLPHENYL ETHER), AN ALKENYL AROMATIC MONOMER, AND AN ALKOXYLATED ACRYLOYL MONOMER; GOOD STIFFNESS, TOUGHNESS, AND HEAT RESISTANCE | GENERAL ELECTRIC COMPANY | 2004-11-02 | — | — | US | disclosed |
| US-6627704-B2 | Blend of polyphenylene ether, styrene compound and acrylic ester | GENERAL ELECTRIC COMPANY | 2003-09-30 | — | — | US | disclosed |
| US-6621684-B2 | Improved stability of electrochemical properties and improved retention of residual voltage, imparted by using an electrolytic solution containing a polymer | MATSUSHITA ELECTRIC INSUSTRIAL CO. LTD. (JP) | 2003-09-16 | — | — | US | disclosed |
| US-20020036884-A1 | Electric double layer capacitor, electrolytic solution therefore and method for suppressing self-discharge in electronic component | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2002-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170107325-A1 | HYDROPHILIC POLYMER DERIVATIVE HAVING CYCLIC BENZYLIDENE ACETAL LINKER | H1-2, H1-0, H1-3 | MIF 3523/4885TAAR1 1591/4885AOC3 2697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.